Recombinant factor VIII exhibits promising profile for the treatment of hemophilia A Feb. 8, 2016 No Comments
Defibrotide deemed effective against veno-oclussive disease in phase III trial Feb. 4, 2016 No Comments
The Medicines Company completes divestiture of hemostasis portfolio to Mallinckrodt Feb. 3, 2016 No Comments
Geron announces the initiation of phase II/III study of imetelstat in patients with MDS Jan. 18, 2016 No Comments
RSS